Zhang, J.-X.; Xing, J.-G.; Wang, L.-L.; Jiang, H.-L.; Guo, S.-L.; Liu, R.
Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways. Molecules 2017, 22, 334.
https://doi.org/10.3390/molecules22030334
AMA Style
Zhang J-X, Xing J-G, Wang L-L, Jiang H-L, Guo S-L, Liu R.
Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways. Molecules. 2017; 22(3):334.
https://doi.org/10.3390/molecules22030334
Chicago/Turabian Style
Zhang, Jun-Xia, Jian-Guo Xing, Lin-Lin Wang, Hai-Lun Jiang, Shui-Long Guo, and Rui Liu.
2017. "Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways" Molecules 22, no. 3: 334.
https://doi.org/10.3390/molecules22030334
APA Style
Zhang, J.-X., Xing, J.-G., Wang, L.-L., Jiang, H.-L., Guo, S.-L., & Liu, R.
(2017). Luteolin Inhibits Fibrillary β-Amyloid1–40-Induced Inflammation in a Human Blood-Brain Barrier Model by Suppressing the p38 MAPK-Mediated NF-κB Signaling Pathways. Molecules, 22(3), 334.
https://doi.org/10.3390/molecules22030334